Abstract
Interpersonal violence increases vulnerability to the deleterious effects of opioid use. Increased opioid prescription receipt is a major contributor to the opioid crisis; however, our understanding of prescription patterns and risk factors among those with a history of interpersonal violence remains elusive. This study sought to identify 5-year longitudinal patterns of opioid prescription receipt among patients experiencing interpersonal violence within a large healthcare system and sociodemographic and clinical characteristics associated with prescription patterns. This secondary analysis examined electronic health record data from January 2004–August 2019 for a cohort of patients (N = 1,587) referred for interpersonal violence services. Latent class growth analysis was used to estimate trajectories of opioid prescription receipt over a 5-year period. Standardized differences were calculated to assess variation in sociodemographic and clinical characteristics between classes. Our cohort had a high prevalence of prescription opioid receipt (73.3%) and underlying co-morbidities, including chronic pain (54.6%), substance use disorders (39.0%), and mental health diagnoses (76.9%). Six prescription opioid receipt classes emerged, characterized by probability of any prescription opioid receipt at the start and end of the study period (high, medium, low, never) and change in probability over time (increasing, decreasing, stable). Classes with the highest probability of prescription opioids also had the highest proportions of males, chronic pain diagnoses, substance use disorders, and mental health diagnoses. Black, non-Hispanic and Hispanic patients were more likely to be in low or no prescription opioid receipt classes. These findings highlight the importance of monitoring for synergistic co-morbidities when providing pain management and offering treatment that is trauma-informed, destigmatizing, and integrated into routine care.
Funder
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention
Publisher
Public Library of Science (PLoS)
Reference62 articles.
1. Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality. CDC Wonder. Atlanta, GA: US Department of Health and Human Services, CDC; 2018 [https://wonder.cdc.gov.
2. Centers for Disease Control and Prevention. 2019 Annual Surveillance Report of Drug-Related Risks and Outcomes—United States Surveillance Special Report. 2019 https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf.
3. Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis;KE Vowles;Pain,2015
4. The changing face of heroin use in the United States: A retrospective analysis of the past 50 years;TJ Cicero;JAMA Psychiatry,2014
5. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study;RG Carlson;Drug Alcohol Depend,2016